RDGT Ridgetech Inc. Insider Trading

10% owner HRT Financial LP buys 41,136 shares at $1.52 blended price, raising stake +69.3% to 100,499 shares amid -99.8% 52-week decline

HRT Financial LP, a 10% shareholder, executed 2 separate open-market purchases totaling 41,136 shares for $62,322.78 at a blended average price of $1.52, increasing holdings from 59,363 to 100,499 shares. The company's stock has fallen 99.8% from its 52-week high of $760.50 to the current price of $1.65, and has declined 55.3% over the past 90 days. The shareholder's cross-ticker track record shows 14 prior buys against 6 prior sells across all holdings. This acquisition represents a substantial 69.3% increase in HRT's post-transaction position at Ridgetech Inc., a micro-cap firm with a market cap of $9.7M, at prices well below recent peaks.

HRT Financial LP (10% owner) bought 19,373 shares of RDGT at $1.61; stock down 99.8% from 52-week high of $760.50

HRT Financial LP acquired 19,373 shares at $1.61 on 2026-06-11, increasing holdings by 16.8% to 134,368 shares post-transaction. The purchase occurred in a stock trading at $1.65, down 99.8% from a 52-week high of $760.50. Over a 30-day window, RDGT has recovered +13.8%, yet remains down 99.5% over 90 days, marking one of the most severe collapses in the 52-week period. The insider's cross-ticker track record shows 13 prior buys with an average 90-day return of +385.9%, though with a 44.44% win rate, indicating mixed outcomes. This transaction represents a material accumulation by a 10% owner at an extreme valuation discount, but occurs against a backdrop of catastrophic price deterioration and without visibility into the drivers of the 99.8% decline.

HRT Financial LP (10% owner) buys 39.3K shares of RDGT in 2 transactions for $67.7K at blended $1.72/share

HRT Financial LP executed 2 separate purchases totaling 39,336 shares for $67,710.24, raising its stake by 52.0% to 114,995 shares post-transaction. The purchases occurred at $1.78 on 2026-06-09 and $1.62 on 2026-06-10, with a blended average price of $1.72. The current price of $1.65 sits at -99.8% from the 52-week high of $760.50, reflecting severe stock deterioration. Across HRT's open-market history on all tickers, prior buys have averaged +385.9% 30-day and 90-day returns with a 44.44% win rate, but these cross-ticker patterns do not establish predictive accuracy at this particular ticker; the 30-day change at RDGT shows +13.8% since these purchases, while the 90-day change is -99.5%.